Regeneron Pharmaceuticals
Regeneron is looking for a Director to lead the Regulatory Sciences team in developing and executing global CMC regulatory strategies across all modalities and product lifecycle stages. The role oversees a team that authors and coordinates CMC submissions from IND/CTA through NDA/BLA and post‑approval, while collaborating with manufacturing, quality, clinical, and program management functions.
Headquarters
Tarrytown, New York, United States
Company Size
10001+ employees
Founded
1988
Discover how Regeneron (NASDAQ: REGN) harmonizes biology and technology to create life-changing medicines. Join our team and explore clinical trials.
Quadrant Capital Group LLC Purchases 1,564 Shares of Regeneron Pharmaceuticals, Inc. $REGN
4 hours ago
In 2036, Investors Will Regret Not Loading Up on This Multibagger in the Making
6 hours ago
Will Positive Obesity Data and Dupixent Expansion Efforts Change Regeneron Pharmaceuticals' (REGN) Narrative?
1 day ago
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for Regeneron Pharmaceuticals.
7% above the average for this role
Regeneron: Fairly Valued Now After A Stellar Upswing (NASDAQ:REGN)
1 day ago
Regulatory CMC Leader
Clinical Dynamix
Director, Regulatory CMC
Neurocrine Biosciences
Executive Director, Regulatory Affairs
Exelixis
Senior Director, Regulatory Affairs CMC – Biologics
Beeline Medicines
Senior Manager, Regulatory Strategy
Beeline Medicines
Senior Director, Global Regulatory Affairs
Jobgether